tiprankstipranks
Immunovia AB (DE:1YR)
FRANKFURT:1YR
Germany Market
1YR
Immunovia AB
RESEARCH TOOLSreports

Immunovia AB (1YR) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

1YR Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Immunovia
AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1YR Stock 12 Month Forecast

There Are No Analyst Ratings for DE:1YR In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

1YR Financial Forecast

1YR Earnings Forecast

Next quarter’s earnings estimate for 1YR is >-€0.01 with a range of >-€0.01 to >-€0.01. The previous quarter’s EPS was >-€0.01. 1YR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.30% of the time in the same period. In the last calendar year 1YR has Performed in-line its overall industry.
Next quarter’s earnings estimate for 1YR is >-€0.01 with a range of >-€0.01 to >-€0.01. The previous quarter’s EPS was >-€0.01. 1YR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.30% of the time in the same period. In the last calendar year 1YR has Performed in-line its overall industry.

1YR Sales Forecast

Next quarter’s sales forecast for 1YR is €45.64K with a range of €45.64K to €45.64K. The previous quarter’s sales results were €34.78K. 1YR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.97% of the time in the same period. In the last calendar year 1YR has Performed in-line its overall industry.
Next quarter’s sales forecast for 1YR is €45.64K with a range of €45.64K to €45.64K. The previous quarter’s sales results were €34.78K. 1YR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.97% of the time in the same period. In the last calendar year 1YR has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - PerPlexity Analyst forecast on DE:1YR
PerPlexity - SonarPro
TipRanks - PerPlexity
TipRanks - PerPlexity
€0.01→€0.01
Hold
45.00%
Upside
Upgraded
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on DE:1YR
Gemini - 3-pro
TipRanks - Google
TipRanks - Google
€0.02→€0.01
Sell
42.26%
Upside
Downgraded
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on DE:1YR
xAI - Grok-3
TipRanks - xAI
TipRanks - xAI
€0.02→€0.01
Hold
45.91%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on DE:1YR
DeepSeek - V3.2-Speciale
TipRanks - DeepSeek
TipRanks - DeepSeek
€0.02→€0.01
Hold
46.82%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on DE:1YR
Anthropic - Opus-4.5
TipRanks - Anthropic
TipRanks - Anthropic
€0.02→€0.01
Hold
44.08%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on DE:1YR
OpenAI - 5.2
TipRanks - OpenAI
TipRanks - OpenAI
€0.02→€0.01
Hold
46.82%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
AI Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - PerPlexity Analyst forecast on DE:1YR
PerPlexity - SonarPro
TipRanks - PerPlexity
TipRanks - PerPlexity
€0.01→€0.01
Hold
45.00%
Upside
Upgraded
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on DE:1YR
Gemini - 3-pro
TipRanks - Google
TipRanks - Google
€0.02→€0.01
Sell
42.26%
Upside
Downgraded
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on DE:1YR
xAI - Grok-3
TipRanks - xAI
TipRanks - xAI
€0.02→€0.01
Hold
45.91%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on DE:1YR
DeepSeek - V3.2-Speciale
TipRanks - DeepSeek
TipRanks - DeepSeek
€0.02→€0.01
Hold
46.82%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on DE:1YR
Anthropic - Opus-4.5
TipRanks - Anthropic
TipRanks - Anthropic
€0.02→€0.01
Hold
44.08%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on DE:1YR
OpenAI - 5.2
TipRanks - OpenAI
TipRanks - OpenAI
€0.02→€0.01
Hold
46.82%
Upside
Reiterated
08/10/26
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
TNYATenaya Therapeutics
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

1YR Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, 1YR has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 1YR average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

1YR Stock Forecast FAQ

What is DE:1YR’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:1YR’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:1YR, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Immunovia AB a Buy, Sell or Hold?
      Currently, no data Available
      What is Immunovia AB’s share price target?
      Currently, no data Available
      What do analysts say about Immunovia AB?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Immunovia AB?
      To buy shares of DE:1YR, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.